Summit Global Investments Dexcom Inc Transaction History

Summit Global Investments

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$112.47 - $130.98 $200,871 - $233,930	1,786 New	1,786 $230,000
Q2 2021 Jan 28, 2022	SELL	$80.99 - $107.93 $287,919 - $383,691	-3,555 Closed	0 $0
Q1 2021 Jan 27, 2022	BUY	$84.79 - $104.74 $301,428 - $372,350	3,555 New	3,555 $1.28 Million

1,084

353M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.